Impact of Sucralose on Gut Microbiota in Crohn's Disease Patients
This study aims to quantify the change in the fecal microbiome of Crohn's Disease patients after consuming Sucralose, as measured by metagenome analysis.
Daily Sucralose Consumption Study
+ Daily Sucralose Consumption Study
Digestive System Diseases+3
+ Gastroenteritis
+ Gastrointestinal Diseases
Basic Science Study
Summary
Study start date: April 18, 2024
Actual date on which the first participant was enrolled.Participation in this study will last for a minimum of 35 days (Phase I: 14-days; baseline with removal of all NNS (eg saccharin, sucralose, steviosides, aspartame, acesulfame-k, erythritol) from the diet, Phase II: 21-days; sucralose intervention, and will involve one virtual visit (study visit 1) and two in-person study visits (study visit 2 and study visit 3). Fecal \& urine samples will be collected before/after each phase. Blood will also be collected.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.40 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Basic Science Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 75 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 3 locations
University Hospitals Cleveland Medical Center
Cleveland, United StatesUH Westlake Health Center
Westlake, United States